News-Medical.Net November 4, 2024
Alimetry

Alimetry has raised an oversubscribed US $18m A2 financing round to commercialize its wearable gut health monitoring device, capitalizing on increased adoption by a growing cohort of US hospitals. This adoption is driven by Alimetry receiving its fourth FDA clearance, the establishment of a CPT III reimbursement code, and the completion of over 30 clinical studies. Alimetry’s flagship AI powered product delivers accurate analysis and diagnosis of gut disorders that have been proven difficult to solve using conventional diagnostics and testing. The oversubscribed round was led by GD1 (Global from Day One), with participation from the American Gastroenterological Association (AGA) GI Opportunity Fund, Olympus Innovation Ventures, IceHouse Ventures, and follow on from existing investors. ​​​​​​​

Nearly one in 10 people...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Investments, Technology, Trends, Wearables
Newer Abbott Libre CGM Sensor Use Now Okay During Imaging
Wearable Devices Help Assess Friedreich's Ataxia Severity Better Than In-Clinic Assessments
10 Promising Advanced Healthcare Technologies In Practice
American Diabetes Association Advises on Hospital CGM Use
HLTH 2024: CGMs Aren’t Just for People with Diabetes Anymore, Dexcom COO Says

Share This Article